Media Resources
About KFF
KFF is the leading health policy organization in the U.S., bringing together substantial capabilities in policy research, polling, and journalism to meet the need for a trusted, independent source of information on national health issues—one with the scope and reach to be a counterweight to health care’s vested interests and a voice for people. Learn more about KFF
Media Contacts
Polling, health reform, health costs, KFF institutional
Craig Palosky
Senior Director of Communications
(202) 347-5270
cpalosky@kff.org
Women’s health, global health, HIV, public health, health information and trust
Mikhaila Richards
Communications Officer
(202) 347-5270
mrichards@kff.org
Medicare, racial equity and health policy, mental health
Chris Lee
Senior Communications Officer
(202) 654-1403
clee@kff.org
Medicaid, the uninsured, KFF Health News
Tammie Smith
Communications Officer
(202) 347-5270
tsmith@kff.org
How to Cite Us
- KFF should be cited as a nonprofit health policy research, polling, and news organization. More about how to cite us.
- KFF encourages news outlets, legislative bodies, academic institutions, and others to link to or reprint our content. More about reprints and permissions.
- KFF logos may only be used to identify our research, polling, journalism, and other work. Request permission to use our logo by emailing logorequests@kff.org.
News Releases
-
Explainer: How States Are Using Medicaid Waivers to Help Incarcerated Individuals Get Care and Transition Back into Their Communities
Compared to the general population, individuals who are incarcerated have higher rates of mental illness, substance use disorder, and chronic disease. However, the federal “inmate exclusion” policy prohibits Medicaid coverage for people who are incarcerated (except for limited inpatient hospital services). … more
-
Could the Comstock Act Be Used to Limit Abortion Access Nationwide?
In a new brief, KFF examines how the Comstock Act, an 1873 anti-vice law banning the mailing of obscene matter and articles, could be used by an anti-abortion presidential administration to sharply restrict the availability of abortion nationwide. … more
-
Nearly a Quarter of People Who Say They Were Disenrolled from Medicaid During the Unwinding Are Now Uninsured
Nearly a quarter (23%) of adults who say they were disenrolled from Medicaid since early 2023 report being uninsured now, finds a new KFF national survey examining how the unwinding affected enrollees. … more
-
Long COVID Rates Appear to be Stabilizing, Affecting About 1 in 10 Adults Who Have Had COVID
Rates of long COVID have begun to flatten. About 1 in 10 adults with COVID have reported having long COVID since rates fell in 2023, according to a KFF analysis of the latest data from the Centers for Disease Control and Prevention. … more
-
One in Five Women of Reproductive Age in States with Abortion Bans Say They or Someone They Know Has Had Difficulty Accessing an Abortion Since Dobbs
According to new KFF polling, in states with abortion bans, one in five (21%) women of reproductive age (18 to 49) and one in seven (14%) of all women say either they or someone they know has had difficulty accessing an abortion since the Supreme Court overturned Roe v. Wade. … more
-
Survey: LGBT Adults Are Twice as Likely as Others to Say They’ve Been Treated Unfairly or with Disrespect by a Doctor or Other Health Care Provider
A third (33%) of LGBT adults say that a doctor or other health care provider treated them unfairly or with disrespect in the past three years – a rate twice as high as reported by people who don’t identify as LGBT (15%), a new KFF survey reveals. … more
-
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss
A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes. … more
-
The Supreme Court, Medication Abortion, and the FDA: What’s at Stake?
In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. … more
-
Most Parents Haven’t Heard Misinformation About the Measles Vaccine though Significant Shares Are Uncertain About the Validity of Claims
As rates of childhood vaccination decline and with measles on the rise again, a KFF Health Misinformation Tracking Poll, fielded in late February, examines the extent to which adults have heard and believe misinformation about the measles vaccine. … more
Subscribe to KFF Emails
Choose which emails are best for you.
Sign up here